All Stories

  1. Variability of Care and Access to Transplantation for Children with Biliary Atresia Who Need a Liver Replacement
  2. Letter to the editor: Liver splitting during ex situ perfusion: Do not count your chickens before they are hatched…
  3. Letter to the editor: Organ shortage and pediatric liver transplantation: David against Goliath…
  4. European Liver Transplant Registry: Donor and transplant surgery aspects of 16,641 liver transplantations in children
  5. Anatomy of reducing left liver lobe grafts and monosegmental liver transplantation: Tell it as it is
  6. Bile duct anatomical variations: Relevance for liver division and preparing left split liver grafts for pediatric transplantation: Cohort study
  7. Optimizing Liver Division Technique for Procuring Left Lateral Segment Grafts: New Anatomical Insights
  8. Domino-liver transplantation: toward a safer and simpler technique in both donor and recipient
  9. Unusual Clinical Course for Untreated Malformative Biliary Atresia Infant
  10. Preliminary Analysis of the Impact of the Coronavirus Disease 2019 Outbreak on Italian Liver Transplant Programs
  11. Novel Arterial Reconstruction With Donor Femoral Artery in Split‐Liver Transplantation
  12. Liver Transplantation for Pediatric Liver Cancer
  13. A Right and a Left … With a Simple Needle…
  14. Case report: horse or zebra, ascites or pseudo-ascites? Care for pictural details!
  15. Cavoportal Hemitransposition in Liver Transplantation: Toward a More Safe and Efficient Technique
  16. Preduodenal Portal Vein Reconstruction at Liver Transplantation: The Challenges and a Solution
  17. A paradigm shift in the intention‐to‐transplant children with biliary atresia: Outcomes of 101 cases and a review of the literature
  18. New Nutritional and Therapeutical Strategies of NEC
  19. Unusual venous collateral pathways allow for reperfusion of the intrahepatic portal venous system in children with portal vein thrombosis after split liver transplantation: Clinical relevance and management implications
  20. A national mandatory‐split liver policy: A report from the Italian experience
  21. Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report
  22. Multimodality imaging of the Meso-Rex bypass
  23. A case of Incontinentia Pigmenti associated with congenital absence of portal vein system and nodular regenerative hyperplasia
  24. Aggressive prevention and preemptive management of vascular complications after pediatric liver transplantation: A major impact on graft survival and long-term outcome
  25. Hepatic vein stenting in a 7 week/old infant with Budd–Chiari syndrome using an anterograde approach from the inferior accessory hepatic vein
  26. Caval replacement strategy in pediatric retroperitoneal tumors encasing the vena cava: a single-center experience and review of literature
  27. CPAP by helmet for treatment of acute respiratory failure after pediatric liver transplantation
  28. More is less: Calling for joining forces for rare pediatric liver tumors research
  29. Pediatric Chronic Intestinal Failure in Italy: Report from the 2016 Survey on Behalf of Italian Society for Gastroenterology, Hepatology and Nutrition (SIGENP)
  30. Hepatoblastoma in children aged less than six months at diagnosis: A report from the SIOPEL group
  31. Early and Late Factors Impacting Patient and Graft Outcome in Pediatric Liver Transplantation
  32. Beyond the Milan criteria for liver transplantation in children with hepatic tumours
  33. Bevacizumab Combined with Chemotherapy in Children Affected by Hepatocellular Carcinoma: a Single-center Experience
  34. Total internal biliary diversion during liver transplantation for type 1 progressive familial intrahepatic cholestasis: a novel approach
  35. Congenital bile duct cyst (BDC) is a more indolent disease in children compared to adults, except for Todani type IV-A BDC: results of the European multicenter study of the French Surgical Association
  36. Liver transplant in ethylmalonic encephalopathy: a new treatment for an otherwise fatal disease
  37. Genetics and Molecular Modeling of New Mutations of Familial Intrahepatic Cholestasis in a Single Italian Center
  38. Reducing left liver lobe grafts, more or less? Don't throw out the baby with the bath water…
  39. Primary prophylaxis of variceal bleeding in children and the role of MesoRex Bypass: Summary of the Baveno VI Pediatric Satellite Symposium
  40. Neonatal massive small bowel resection: How much the multidisciplinary approach does impact on the outcome?
  41. Congenital double intrahepatic portosystemic shunt: Imaging findings and endovascular closure
  42. Splitting livers: Trans-hilar or trans-umbilical division? Technical aspects and comparative outcomes
  43. Optimization and planning of operating theatre activities: an original definition of pathways and process modeling
  44. Roux-en-Y hepatico-jejunostomy for a left segmental graft: Do not twist the loop, stick it!
  45. Pancreatitis and Portal Vein Thrombosis in Children: The Chicken or the Egg Causality Dilemma
  46. P1238 : Intermediate familial intrahepatic cholestasis (IFIC): Phenotypic spectrum within the BRIC-PFIC spectrum
  47. Unusual Tract & Complication of a Percutaneous Gastrostomy Tube (PEG) in a Patient with End-Stage Liver Disease
  48. Congenital Meso-Rex Bypass
  49. Meso-Rex bypass to manage prehepatic portal hypertension after the failure of an intrahepatic portosystemic stent shunting
  50. Liver transplantation in metabolic diseases: Clinical data in Rome
  51. Intestinal failure associated liver disease in a short bowel syndrome pediatric cohort: Incidence and prognosis
  52. Living donor liver transplant (LDLT): The patient perspective
  53. Central venous catheter infections in home parenteral nutrition: Changes in two last decades in a pediatric cohort of short bowel syndrome
  54. Intrahepatic portal venous systems in children with noncirrhotic prehepatic portal hypertension: Anatomy and clinical relevance
  55. Hepatic venous reconstruction as the stake of the liver: Technical note and thoughts
  56. Preemptive Meso-Rex Bypass for Children With Idiopathic Prehepatic Portal Hypertension
  57. Long-Term Outcome of Home Parenteral Nutrition in Patients With Ultra-Short Bowel Syndrome
  58. Pancreaticoduodenectomy for malignancies in children
  59. YouTube and Pediatric Surgery. What Is the Danger for Parents?
  60. Prehepatic portal hypertension with aneurysm of the portal vein: Unusual but treatable malformative pattern
  61. Hepatoblastoma state of the art
  62. Meso-Rex Bypass—A Procedure to Cure Prehepatic Portal Hypertension: The Insight and the Inside
  63. Focal congenital hyperinsulinism managed by medical treatment: a diagnostic algorithm based on molecular genetic screening
  64. Non-alcoholic fatty liver disease and hepatocellular carcinoma in a 7-year-old obese boy: coincidence or comorbidity?
  65. Transplantation for liver tumors in children: Time to (re)set the guidelines?
  66. Giant Varicocele Inducing Chronic Pelvic Pain in a Girl
  67. Pediatric post-transplant metabolic syndrome: New clouds on the horizon
  68. ERCP with intracholedocal biopsy for the diagnosis of biliary tract rhabdomyosarcoma in children
  69. Surgically assisted trans-hepatic anterior approach for central venous catheter placement: Safety and efficacy
  70. Meso-Rex bypass as an alternative technique for portal vein reconstruction at or after liver transplantation in children: Review and perspectives
  71. Surgical management of portal hypertension in children
  72. Immediate use of an arteriovenous prosthetic graft for life-saving dialysis in a child
  73. Portal hypertension in children
  74. Congenital intrahepatic portohepatic shunt managed by interventional radiologic occlusion: a case report and literature review
  75. Too late to say it is too early - How to get children with non-cirrhotic metabolic diseases transplanted at the right time?
  76. Liver transplantation for refractory severe pruritus related to widespread multifocal hepatic focal nodular hyperplasia (FNH) in a child: Case report and review of literature
  77. Staged abdominal closure after small bowel or multivisceral transplantation
  78. Successful Tenofovir Treatment for Fulminant Hepatitis B Infection in an Infant
  79. CO6 LIVER TRANSPLANTATION IN CHILDREN: PRELIMINARY DATA IN ROME, OSPEDALE BAMBINO GESÙ
  80. Metabolic syndrome and nonalcoholic steatohepatitis recurrence after liver transplantation in children
  81. Unresectable multifocal omental and peritoneal inflammatory myofibroblastic tumor in a child: revisiting the role of adjuvant therapy
  82. With great power comes great responsibility - What pediatricians referring babies and small children to radiological interventions should know
  83. The new Guillemins station - a railway station for high-speed trains
  84. Congenital Hyperinsulinism and Glucose Hypersensitivity in Homozygous and Heterozygous Carriers of Kir6.2 (KCNJ11) Mutation V290M Mutation: KATP Channel Inactivation Mechanism and Clinical Management
  85. Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease
  86. Preemptive liver transplantation in a child with familial hypercholesterolemia
  87. P259 - Fermeture pariétale différée après transplantation intestinale ou multiviscérale
  88. Steatosis and fibrosis in paediatric liver transplant: Insidious graft’s enemies - A call for clinical studies and research
  89. Mesoportal bypass for extrahepatic portal vein obstruction in children: close to a cure for most!
  90. Psychosocial Condition After Liver Transplantation in Children: Review of the Literature From 2006 to 2008
  91. Innovative surgical techniques address the organ donation crisis, … donʼt they?
  92. Multiorgan developmental anomalies presenting as a variation of the serpentine-like syndrome: cervical fusion and brachioesophagus with intrathoracic stomach and malposition of duodenopancreas and spleen
  93. Expanding Postmortem Donor Pool Using Steatotic Liver Grafts: A New Look
  94. Isolated Liver Transplant in Infants With Short Bowel Syndrome: Insights Into Outcomes and Prognostic Factors
  95. Primary Hepatic Tumors
  96. DESCRIPTION AND MICROSCALE ANALYSIS OF SOME ENIGMATIC PALYNOMORPHS FROM THE MIDDLE DEVONIAN (GIVETIAN) OF LIBYA
  97. A new strategy for analysis of erection stages including an efficient method for creep analysis
  98. Congenital Intrahepatic Bile Duct Dilatation is a Potentially Curable Disease
  99. Immunological monitoring after organ transplantation: Potential role of soluble CD30 Blood level measurement
  100. Liver Transplantation Using Non-Heart-Beating Donors: Belgian Experience
  101. Early occurrence of hepatocellular carcinoma in biliary atresia treated by liver transplantation
  102. Living-Related Versus Deceased Donor Pediatric Liver Transplantation: A Multivariate Analysis of Technical and Immunological Complications in 235 Recipients
  103. Successful treatment of refractory ascites in a child with transjugular intrahepatic portosystemic shunt
  104. Autorenverzeichnis
  105. Die kongenitale zystische Dilatation der Gallengänge
  106. Early immunological monitoring after pediatric liver transplantation: Cytokine immune deviation and graft acceptance in 40 recipients
  107. 2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group
  108. Surgical guidelines for the management of extra-hepatic portal vein obstruction
  109. Expert pediatric opinion on the Report of the Baveno IV Consensus Workshop on Methodology of Diagnosis and Therapy in Portal Hypertension
  110. Pyloric obstruction, duodenal dilatation, and extrahepatic cholestasis: a neonatal triad suggesting multiple intestinal atresias
  111. Conservative management of pneumatosis intestinalis following haematopietic stem cell transplantation for major β thalassemia
  112. Safety of living-related liver transplantation for progressive familial intrahepatic cholestasis
  113. Foreword
  114. Isolated Liver Transplantation in an Infant With Ultrashort Gut
  115. Pediatric liver transplantation using left hepatic segments from living related donors: Surgical experience in 100 recipients at Saint-Luc University Clinics
  116. Management of End-stage Central Venous Access in Children Referred for Possible Small Bowel Transplantation
  117. Improved outcome of referrals for intestinal transplantation in the UK
  118. Recurrent Mesenchymal Hamartoma Associated with 19q Translocation. A Call for More Radical Surgical Resection
  119. 3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome
  120. Liver allograft radiotherapy to treat rejection in children: efficacy in orthotopic liver transplantation and long-term safety
  121. The contribution of transplantation to the treatment of liver tumors in children
  122. Liver transplantation for hepatoblastoma: Indications and contraindications in the modern era
  123. Cryopreserved Liver Cell Transplantation Controls Ornithine Transcarbamylase Deficient Patient While Awaiting Liver Transplantation
  124. Right-sided diaphragmatic hernia in infants after liver transplantation
  125. PELD Score and Posttransplant Outcome in Pediatric Liver Transplantation: A Retrospective Study of 100 Recipients
  126. CHIMERIC ENGRAFTMENT AND TISSUE ENZYME ACTIVITY AFTER LIVER CELL TRANSPLANTATION FOR ARGININOSUCCINATE-LYASE DEFICIENCY
  127. Split-Liver Transplantation for the Pediatric and Adult Recipient
  128. The role of Notch receptor expression in bile duct development and disease
  129. PELD SCORES IN PEDIATRIC LIVER TRANSPLANTATION: A RETROSPECTIVE STUDY IN 100 CHILDREN.
  130. P0193 SAFETY OF INTRAFAMILIAL LIVING-RELATED LIVER TRANSPLANTATION FOR PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS
  131. P0227 REPEATED LIVER CELL TRANSPLANTATION VIA PORTH A CATH SYSTEM IN A CHILD
  132. P0772 SMALL BOWEL TRANSPLANT (SBTX) IN CHILDREN: A DECADE OF EXPERIENCE FROM A SINGLE CENTRE
  133. P0250* SAFETY AND EFFICACY OF SIROLIMUS IN CHILDREN FOLLOWING CHRONIC REJECTION AND/OR NEPHROTOXICITY POST INTESTINAL TRANSPLANT (ITX) AND LIVER TRANSPLANTATION (LTX).
  134. Seamless management of biliary atresia in England and Wales (1999–2002)
  135. Management of hepatic epithelioid haemangio-endothelioma in children: what option?
  136. Permanent access to the portal system for cellular transplantation using an implantable port device
  137. Bile duct of luschka leading to bile leak after cholecystectomy—revisiting the biliary anatomy
  138. Familial Hepatoblastoma and APC gene mutations: renewed call for molecular research
  139. Meso-portal bypass in children with portal vein thrombosis: rapid increase of the intrahepatic portal venous flow after direct portal hepatic reperfusion
  140. Renal function following liver transplantation for unresectable hepatoblastoma
  141. Risk factors for death and graft loss after small bowel transplantation
  142. Worth Continuing Doing Ex Situ Liver Graft Splitting? A Single-Center Analysis
  143. Partial splenectomy in cystic fibrosis patients with hypersplenism
  144. Congenital, solitary, large, intrahepatic arterioportal fistula in a child: management and review of the literature
  145. New perspective for the management of near-total or total intestinal aganglionosis in infants
  146. Congenital malignant peritoneal mesothelioma
  147. Progenitor cells of the biliary epithelial cell lineage
  148. Ex Situ Preparation of Left Split-Liver Grafts With Left Vascular Pedicle Only: Is it Safe?
  149. Hepatic vein reconstruction in ex situ split-liver transplantation
  150. Benefits of early diagnosis and preemptive treatment of biliary tract complications after major blunt liver trauma in children
  151. Difficult Management Choices For Infants With Short Bowel Syndrome and Liver Failure
  152. Induction therapy for small bowel transplant recipients: early experience in Birmingham, UK
  153. Neonatal Liver Transplantation for Fulminant Hepatitis Caused by Herpes Simplex Virus Type 2
  154. Transhepatic Hickman Line Placement: Improving Line Stability by Surgically Assisted Radiologic Placement
  155. Improved technique of portal vein reconstruction in pediatric liver transplant recipients with portal vein hypoplasia
  156. Inferior Vena Cava Occlusion and Protein-losing Enteropathy After Liver Transplantation in Children
  157. Strategy for hepatoblastoma management: Transplant versus nontransplant surgery
  158. Techniques for and outcome of liver transplantation in neonates and infants weighing up to 5 kilograms
  159. VENTILATORY FAILURE AFTER PEDIATRIC LIVER TRANSPLANTATION
  160. Technique for ex situ cadaveric liver graft division
  161. THE USE OF LIVER GRAFTS FROM DONORS WITH BACTERIAL MENINGITIS
  162. Liver transplantation in children
  163. Early experience of paediatric intestinal transplantation in the United Kingdom, 1993 to 1999
  164. Treatment of Microvillus Inclusion Disease by Intestinal Transplantation
  165. ABSENCE OF THE LEFT PORTAL VEIN: A DIFFICULTY FOR REDUCTION OF LIVER GRAFTS?
  166. Size Reduction of Small Bowels from Adult Cadaveric Donors to Alleviate the Scarcity of Pediatric Size-Matched Organs: An Anatomical and Feasibility Study. Transplantation 2000; 69: 1392.
  167. EN BLOC COMBINED REDUCED-LIVER AND SMALL BOWEL TRANSPLANTS
  168. Pseudo-obstruction in children: transplant or wait?
  169. Treatment of Extrahepatic Portal Hypertension in Children by Mesenteric-to-left Portal Vein Bypass: a New Physiological Procedure
  170. PRESERVED VASCULAR HOMOGRAFT FOR REVASCULARIZATION OF PEDIATRIC LIVER TRANSPLANT1
  171. TECHNICAL-VARIANT LIVER GRAFTS IN PEDIATRIC LIVER TRANSPLANTATION: BACK TO THE FUTURE
  172. TREATMENT OF MICROVILLUS INCLUSION DISEASE BY INTESTINAL TRANSPLANTATION : RETENTION OF THE NATIVE ILEOCAECAL VALVE AND COLON IMPROVES OUTCOME
  173. Cricopharyngeal Achalasia: Case Reports and Review of the Literature
  174. Pediatric liver transplantation with cadaveric or living related donors: Comparative results in 90 elective recipients of primary grafts
  175. Intraabdominal pyloromyotomy through the umbilical route: A technical improvement
  176. Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients
  177. Conversion from tacrolimus to microemulsion formulation of cyclosporine in pediatric liver transplantation
  178. Gastric Cystic Duplication Communicating with a Bifid Pancreas: A Rare Cause of Recurrent Pancreatitis
  179. Pediatric liver transplantation: from the full-size liver graft to reduced, split, and living related liver transplantation
  180. Use of granulocyte macrophage colony stimulating factor in children after orthotopic liver transplantation
  181. REJECTION INCIDENCES AFTER PEDIATRIC LIVER TRANSPLANTATION WITH CADAVERIC OR LIVING-RELATED DONORS: AN IMMUNOLOGICAL PARADOX?
  182. ETHICAL ISSUES IN LIVING RELATED (LR) OR CADAVERIC (Cad) PEDIATRIC LIVER TRANSPLANTATION (OLT)
  183. PEDIATRIC LIVER TRANSPLANTATION : FROM THE FULL-SIZE LIVER GRAFT(FS) TO THE REDUCED (RED), SPLIT AND LIVING RELATED LIVER TRANSPLANTATION(LRLT)
  184. FIVE YEARS POST TRANSPLANT STATUS IN 96 CHILDREN WHO RECEIVED OLT BETWEEN 1984 AND 1990
  185. REJECTION INCIDENCES AFTER PEDIATRIC LIVER TRANSPLANTATION WITH CADAVERIC OR LIVING-RELATED DONORS: AN IMMUNOLOGICAL PARADOX?
  186. ETHICAL ISSUES IN LIVING RELATED (LR) OR CADAVERIC (Cad) PEDIATRIC LIVER TRANSPLANTATION (OLT).
  187. PEDIATRIC LIVER TRANSPLANTATION : FROM THE FULL-SIZE LIVER GRAFT(FS) TO THE REDUCED (RED), SPLIT AND LIVING RELATED LIVER TRANSPLANTATION(LRLT).
  188. FIVE YEARS POST TRANSPLANT STATUS IN 96 CHILDREN WHO RECEIVED OLT BETWEEN 1984 AND 1990.
  189. FIVE YEARS POST TRANSPLANT STATUS IN 96 CHILDREN WHO RECEIVED OLT BETWEEN 1984 AND 1990
  190. PRELIMINARY ANALYSIS OF LONGITUDINAL GROWTH MEASUREMENTS AMONG 384 CHIDREN WHO RECEIVED OLT BETWEEN 1984 AND 1995.
  191. Direct bypassing of extrahepatic portal venous obstruction in children: A new technique for combined hepatic portal revascularization and treatment of extrahepatic portal hypertension
  192. Delayed primary closure of the abdominal wall after cadaveric and living related donor liver graft transplantation in children: a safe and useful technique
  193. EARLY HEPATOCYTE, ENDOTHELIAL, AND BILE DUCT CELL INJURY AFTER PEDIATRIC LIVER TRANSPLANTATION FROM CADAVERIC OR LIVING-RELATED DONORS
  194. Delayed primary closure of the abdominal wall after cadaveric and living related donor liver graft transplantation in children: a safe and useful technique
  195. Granulocyte macrophage colony stimulating factor (GM-CSF) chez les receveurs de transplants hépatiques
  196. FK506 et syndromes lymphoprolifératifs chez les enfants transplantés hépatiques
  197. Arteriomesenteric syndrome as a cause of duodenal obstruction in children with cerebral palsy
  198. Clinical pharmacokinetics of Neoral in pediatric recipients of primary liver transplants
  199. Early Signs And Risk Factors For The Increased Incidence Of Epstein-Barr Virus-Related Posttransplant Lymphoproliferative Diseases In Pediatric Liver Transplant Recipients Treated With Tacrolimus
  200. Hirschsprung's disease: A 20-year experience
  201. Cavocaval liver transplantation without venovenous bypass and without temporary portocaval shunting: the ideal technique for adult liver grafting?
  202. RISK FACTORS FOR THE INCREASED INCIDENCE OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS TREATED WITH TACROLIMUS
  203. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC STENT SHUNT (TIPSS) IN CHILDREN.
  204. Adult liver transplantation and abnormalities of splanchnic veins: experience in 53 patients
  205. Adult liver transplantation and abnormalities of splanchnic veins: experience in 53 patients
  206. ORIGINAL EXTRAHILAR APPROACH FOR HEPATIC PORTAL REVASCULARIZATION AND RELIEF OF EXTRAHEPATIC PORTAL HYPERTENSION RELATED TO LATE PORTAL VEIN THROMBOSIS AFTER PEDIATRIC LIVER TRANSPLANTATION
  207. PROPHYLACTIC IMMUNOSUPPRESSION WITH ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL ANTIBODY LO-TACT-1 VERSUS OKT3 IN LIVER ALLOGRAFTING
  208. GLUCURONIDATION OF DIFLUNISAL, (−)-MORPHINE, 4-NITROPHENOL, AND PROPOFOL IN LIVER MICROSOMES OF TWO PATIENTS WITH CRIGLER–NAJJAR SYNDROME TYPE I
  209. 121 RELIEF OF EXTRAHEPATIC PORTAL HYPERTENSION DUE TO PORTAL VEIN THROMBOSIS IN CHILDREN: ORIGINAL EXTRAHILAR APPROACH.
  210. 34 LIVING RELATED LIVER TRANSPLANTATION: THE FIRST 2 1/2 YEAR EXPERIENCE IN BRUSSELS.
  211. Extrahepatic glucuronidation of propofol in man: possible contribution of gut wall and kidney
  212. Laparoscopic splenectomy in adults and children: Experience with 31 patients
  213. MICROEMULSION FORMULATION OF CYCLOSPORINE IN PEDIATRIC LIVER TRANSPLANTATION
  214. Primary calcification in post-transplantation lymphoproliferative disorder involving the hepatic graft: an exceptional finding
  215. Devenir au long cours des enfants transplantés hépatiques
  216. ORTHOTOPIC LIVER TRANSPLANTATION FOR CRIGLER-NAJJAR TYPE I DISEASE IN SIX CHILDREN
  217. Mitochondrial respiratory chain defect: a new etiology for neonatalcholestasis and early liver insufficiency
  218. Standardized quick en bloc technique for procurement of cadaveric liver grafts for pediatric liver transplantation
  219. SPLIT LIVER TRANSPLANTATION IN EUROPE—1988 to 1993
  220. Primary management of biliary atresia: Don't change the rules
  221. Role of hepatitis C virus in chronic liver disease occurring after orthotopic liver transplantation.
  222. 21 RESCUE FK 506 THERAPY FOR RESISTANT REJECTION AFTER PEDIATRIC LIVER TRANSPLANTATION (OLT)
  223. A new method for rat accessory hepatic transplantation-the cervical approach
  224. A new method for rat accessory hepatic transplantation ? the cervical approach
  225. Percutaneous transjugular intrahepatic stent shunt for treatment of intractable varicose bleeding in paediatric patients
  226. Hepatobiliary scintigraphy in a patient with bilhemia
  227. Sequential treatment of biliary atresia with kasai portoenterostomy and liver transplantation: A review
  228. Technical problems in shipped hepatic allografts: the UCL experience
  229. Technical problems in shipped hepatic allografts: the UCL experience
  230. Sequential treatment of biliary atresia with Kasai portoenterostomy and liver transplantation: A review*1
  231. LIVER PROCUREMENT WITHOUT IN SITU PORTAL PERFUSION
  232. CONVERSION FROM CYCLOSPORINE TO FK506 FOR SALVAGE OF IMMUNOCOMPROMISED PEDIATRIC LIVER ALLOGRAFTS EFFICACY, TOXICITY, AND DOSE REGIMEN IN 23 CHILDREN
  233. Impact Of Innovative Techniques On The Waiting List And Results In Pediatric Liver Transplantation
  234. THE UNRELIABILITY OF THE LIDOCAINE/MONOETHYLGLYCINEXYLIDIDE TEST FOR ASSESSMENT OF LIVER DONORS
  235. Management of intra-abdominal organ injury following blunt abdominal trauma in children
  236. MONOCLONAL ANTIBODIES IN PROPHYLACTIC IMMUNOSUPPRESSION AFTER LIVER TRANSPLANTATION A RANDOMIZED CONTROLLED TRIAL COMPARING OKT3 AND ANTI-IL-2 RECEPTOR MONOCLONAL ANTIBODY LO-TACT-1
  237. Progressive cardiac failure following orthotopic liver transplantation for type IV glycogenosis
  238. Acute adenovirus hepatitis in liver transplant recipients
  239. Platelet aggregates in small lung vessels and death during liver transplantation
  240. Liver transplantation in children with biliary atresia and polysplenia syndrome
  241. 53 LIVER TRANSPLANTATION FOR METABOLIC DISORDERS IN CHILDREN
  242. Unifocal Stricture of the Common Bile Duct in Two Children
  243. Liver transplantation in children less than 1 year of age
  244. LIVER TRANSPLANTATION BEFORE ONE YEAR
  245. Size Reduction of the Donor Liver Is a Safe Way to Alleviate the Shortage of Size-Matched Organs in Pediatric Liver Transplantation
  246. Obstruction to hepatic venous drainage after liver transplantation: treatment with balloon angioplasty.
  247. Acute and fulminant adenovirus hepatitis in liver transplant recipients: Diagnosis and management
  248. Liver Transplantation for Biliary Atresia: Indications and Results
  249. Pediatric liver transplantation: Report on 52 patients with a 2-year survival of 86%
  250. Primary Hepatic Tumours
  251. Liver tumors and resections